Clinical Trial Update: Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A booster administration study of GAD-alum (Diamyd®) in individuals with Type 1 diabetes has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Diamyd

Snippet

Sponsor: Linkoeping University | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: COMPLETED